Delivery Order SPE2DB22D1052-SPE2DB26FU7UC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram units, valued at $2,502.11. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract was executed with an ultimate completion date of September 4, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,941.77 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram units. This firm fixed price, non-set-aside contract is scheduled for completion by August 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Naftifine HCL 1% Cream in 60-gram quantities, with a ceiling value of $1,625.15 and a completion date of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA Troop Support Medical. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,128.62 to AmerisourceBergen Drug Corp for Naftifine HCL 2% Cream in 45-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 8, 2025. The award was issued on September 5, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,961.53 to AmerisourceBergen Drug Corp for Naftifine HCL 1% Cream in 60-gram units. This firm fixed-price contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside delivery order under DLA's pharmaceutical supply chain. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naftifine HCL 1% Cream in 60-gram units with a ceiling value of $4,706.55. This competitively awarded, firm fixed-price delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025. The contract carries no set-aside designation, and performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $6,904.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram quantities. The contract, which is non-set-aside and competitively awarded, specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,939.04 to AmerisourceBergen Drug Corp for Naftifine HCL 2% Gel in 45-gram units. This competitively awarded, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $128,090 firm fixed price delivery order to AmerisourceBergen Drug Corporation for NAFTIFINE HCL 2% CREAM 45GM. The single award delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and will be performed by AmerisourceBergen in Conshohocken, Pennsylvania between September 8-11, 2023. As a leading provider of pharmaceuticals and medical supplies, AmerisourceBergen will deliver the antifungal skin cream to support...
- The Defense Logistics Agency awarded a $1,364.53 delivery order to AmerisourceBergen Drug Corp for Naftifine HCL 2% Gel 60GM, a topical antifungal medication. This firm fixed price, non-set-aside contract is scheduled for completion by September 5, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB26FU7UCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Naftifine HCL 2% Cream in 60-gram quantities, with a ceiling value of $8,129.88 and completion targeted for October 15, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, maintains extensive federal contracting experience supplying medications and medical supplies to military and veteran healthcare systems. The company's $1 billion IDC with DLA enables it to provide a diverse range of pharmaceutical products and medical supplies—including specialty medications, generic and brand-name drugs, vaccines, and associated medical commodities—to support Defense Health Agency programs and other federal healthcare systems globally. This particular delivery order for topical antifungal medication represents a routine procurement under that umbrella contract, leveraging AmerisourceBergen's established capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 10/14/25 |